1 / 34

Tara Daniel

Stage 1 Meaningful Use . Tara Daniel. May 18, 2012. Objectives. Overview of Meaningful Use. Measure Insight. Attestation Process. MU Overview. Measure Insight. Attestation Process. Overview. Long-term Initiative. Changes Over Time.

enye
Télécharger la présentation

Tara Daniel

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Stage 1 Meaningful Use Tara Daniel May 18, 2012

  2. Objectives Overview of Meaningful Use Measure Insight Attestation Process MU Overview Measure Insight Attestation Process

  3. Overview Long-term Initiative Changes Over Time Central to Health Information Technology MU Overview Measure Insight Attestation Process

  4. Timeline July 2010 CMS Final Rule for Incentive Program April 2012 TennCare accepts MU attestations 2021 Program End 2009 HITECH Act June 2010 ONC Final Rule for EHR Certification January 2011 TennCare accepts AIU attestations 2016 Last Year to Begin Program MU Overview Measure Insight Attestation Process

  5. Meaningful Use Improve Quality, Safety, Efficiency, and Reduce Health Disparities Engage Patients and Families in their Healthcare Improve Care Coordination Improve Population and Public Health Maintain Privacy and Security MU Overview Measure Insight Attestation Process

  6. Quality Oversight Role informed Promote Participation responsible relevant Facilitate Successful Attestation Facilitate Successful Attestation Evaluate Attestations Evaluate Attestations Collect and Analyze Data MU Overview Measure Insight Attestation Process

  7. Meaningful Use Process MU Overview Measure Insight Attestation Process

  8. Incentive Payments Payment Year Program Requirements Payment 1 AIU $21,250 2 Stage 1 MU $8,500 3 Stage 1 MU $8,500 2014 4 Stage 2 MU $8,500 5 Stage 2 MU $8,500 6 Stage 3 MU $8,500 $63,750 MU Overview Measure Insight Attestation Process

  9. Meaningful Use Process EP/EH Processes Performed Meaningful Use Prepared Attested Data Compiled, Published Verified Audited Paid TennCare Processes MU Overview Measure Insight Attestation Process

  10. TennCare as a Resource Clarify and Affirm Meaningful Use Criteria Aid in the Attestation Process Address Specific Questions and Concerns MU Overview Measure Insight Attestation Process

  11. Scope and Applicability Medicaid EHR Incentive Program Eligible Professionals (EPs) Meaningful Use MU Overview Measure Insight Attestation Process

  12. Measure Insight Types of Measures Prepared Vendors Measure Parameters EPs Performed Consultants (Optional) Measure Concerns Attested MU Overview Measure Insight Attestation Process

  13. Stage 1 Meaningful Use 15 Core Measures 5 of 10 Menu Measures 6-9 Clinical Quality Measures MU Overview Measure Insight Attestation Process

  14. Types of Measures numerator Calculated Percentage denominator 3 Problem Lists Measure at a Glance Type: calculated percentage Denominator: unique patients Duration: calculated over the entire EHR reporting period More than 80 percent of all unique patients seen by the EP have at least one entry or an indication that no problems are known for the patient as structured data. MU Overview Measure Insight Attestation Process

  15. Types of Measures Yes Task to be Performed Calculated Percentage No 3 Patient Lists Measure at a Glance Type: task to be performed Denominator: none Duration: completed during the EHR reporting period Generate at least one report listing patients of the EP with a specific condition. MU Overview Measure Insight Attestation Process

  16. Types of Measures Yes Enabled Function No 1 Drug Formulary Checks Measure at a Glance Type: enabled function Denominator: none Duration: enabled during the entire EHR reporting period The EP has enabled this functionality and has access to at least one internal or external formulary for the entire EHR reporting period. MU Overview Measure Insight Attestation Process

  17. Measure Categories MU Overview Measure Insight Attestation Process

  18. Unique Patients More than 80 percent of all unique patients seen by the EP have at least one entry or an indication that no problems are known for the patient as structured data. More than 80 percent of all unique patients seen by the EP have at least one entry (or an indication that the patient is not currently prescribed any medication) recorded as structured data. More than 80 percent of all unique patients seen by the EP have at least one entry (or an indication that the patient has no known medication allergies) recorded as structured data. More than 50 percent of all unique patients seen by the EP have demographics recorded as structured data. MU Overview Measure Insight Attestation Process

  19. Based on Subset Measure at a Glance Type: calculated percentage Denominator: unique patients with a medication list, which may be limited to patients maintained by CEHRT Duration: calculated over the entire EHR reporting period More than 30 percent of all unique patients with at least one medication in their medication list seen by the EP have at least one medication order entered using CPOE. MU Overview Measure Insight Attestation Process

  20. Core Measure 12 12 Measure at a Glance Type: calculated percentage Denominator: unique patients requesting copies at least four days prior to the end of the reporting period, may be limited to patients maintained by CEHRT Duration: calculated over the entire EHR reporting period Electronic Copies More than 50 percent of all patients who request an electronic copy of their health information are provided it within 3 business days. MU Overview Measure Insight Attestation Process

  21. Menu Measure 5 5 Patient Electronic Access Measure at a Glance Type: calculated percentage Denominator: unique patients Duration: calculated over the entire EHR reporting period At least 10 percent of all unique patients seen by the EP are provided timely (available to the patients within four business days of being updated in the certified EHR technology) electronic access to their health information subject to the EP's discretion to withhold certain information. MU Overview Measure Insight Attestation Process

  22. Core Measure 13 13 Measure at a Glance Type: calculated percentage Denominator: office visits Duration: calculated over the entire EHR reporting period Clinical Summaries Clinical summaries provided to patients for more than 50 percent of all office visits within 3 business days. MU Overview Measure Insight Attestation Process

  23. Core Measure 14 14 Exchange Information Measure at a Glance Type: task to be performed Denominator: none Duration: completed any time during the reporting period’s year, so long that the date is on or before the last day of the reporting period Performed at least one test of certified EHR technology’s capacity to electronically exchange key clinical information. MU Overview Measure Insight Attestation Process

  24. Attestation Process MU Overview Measure Insight Attestation Process

  25. Navigating to the Portal MU Overview Measure Insight Attestation Process

  26. Attestation Process http://pipp.tenncare.tn.gov AIU MU Overview Measure Insight Attestation Process

  27. General Questions EHR Reporting Period Number of Unique Patients in EHR County of Practice Provider Specialty MU Overview Measure Insight Attestation Process

  28. Core & Menu Measures 2 3 MU Overview Measure Insight Attestation Process

  29. Core & Menu Measures 3 Patient Lists Measure at a Glance Type: task to be performed Denominator: none Duration: completed during the EHR reporting period Generate at least one report listing patients of the EP with a specific condition. MU Overview Measure Insight Attestation Process

  30. Core & Menu Measures 11 Measure at a Glance Type: enabled function Denominator: none Duration: enabled during the entire reporting period Clinical Decision Support Implement one clinical decision support rule. 4 eRx Measure at a Glance Type: calculated percentage Denominator: permissible prescriptions Duration: calculated over the entire EHR reporting period More than 40 percent of all permissible prescriptions written by the EP are transmitted electronically using certified EHR technology. MU Overview Measure Insight Attestation Process

  31. Core & Menu Measures 9 Measure at a Glance Type: task to be performed Denominator: none Duration: completed any time during the reporting period’s year, so long that the date is on or before the last day of the reporting period Immunization Registry Performed at least one test of CEHRT’s capacity to submit electronic data to immuniza-tion registries and follow up submissions if the test is successful (unless none of the immunization registries to which the EP submits such information has the capacity to receive the information electronically) MU Overview Measure Insight Attestation Process

  32. Clinical Quality Measures Attest to the 3 Core CQMs Automatically Instruct How Many Alternate Core (0-3) Select 3 Additional CQMs MU Overview Measure Insight Attestation Process

  33. Attestation Tips Review Measures Before Attesting Save and Exit to Return Later Be Thorough Proofread Be Early MU Overview Measure Insight Attestation Process

  34. TennCare Resources Attestation Webinar: May 23, 2012: 9:00 AM, Recorded TennCare Website: http://tn.gov/tenncare/mu.shtml E-mail Address: EHRMeaningfulUse.TennCare@tn.gov MU Overview Measure Insight Attestation Process

More Related